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Abstract
Background—We previously reported that the cytochrome P450 product 20-
hydroxyeicosatetraenoic acid has prosurvival effects in pulmonary artery endothelial cells and ex
vivo pulmonary arteries. We tested the potential of a 20-hydroxyeicosatetraenoic acid analog N-
[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine (20-5,14-HEDGE) to protect against lung ischemic
reperfusion injury in rats. Furthermore, we examined activation of the innate immune system
components high mobility group box 1 (HMGB1) and toll-like receptor 4 in this model as well as
the effect of 20-5,14-HEDGE on this signaling pathway.
Methods—Sprague Dawley rats treated with 20-5,14-HEDGE or vehicle were subjected to
surgically induced, unilateral lung ischemia for 60 minutes followed by reperfusion for two hours
in vivo. Injury was assessed histologically by hematoxylin and eosin, and with identification of
myeloperoxidase immunohistochemically. HMGB1 and toll-like receptor 4 proteins were
identified by western blot. Caspase 3 activity or 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide, a yellow tetrazole incorporation were used to measure apoptosis and
cell survival.
Results—IR injury evoked atelectasis and hemorrhage, an influx of polymorphonuclear cells,
and increased toll-like receptor 4 and HMGB1 expression. Caspase 3 activity was increased and
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide incorporation was decreased.
20-5,14-HEDGE protected against each of these endpoints including infiltration of
polymorphonuclear cells, with no changes in caspase 3 activity in other organs.
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Conclusions—Lung IR produces apoptosis and activation of the innate immune system
including HMGB1 and toll-like receptor 4 within two hours of reperfusion. Treatment with
20-5,14-HEDGE decreases activation of this response system, and salvages lung tissue.
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Introduction
Inflammatory responses by the innate immune system characterize ischemia reperfusion
(IR) injury in the heart, liver, and brain and are triggered in part by binding of endogenous
danger molecules such as High Mobility Group Box 1 (HMGB1) to Toll like receptors
(TLRs), in particular TLR4 (1,2). Though they have distinct pathophysiologic mechanisms,
conditions such as crush injury to the chest, lung transplantation, cardiopulmonary bypass,
and others are believed to share some manifestation(s) of IR injury. The role of TLR4 in
warm ischemic (in vivo) lung injury is supported by blunted microvascular permeability
injury and decreased activation of NF-κβ and MAPKs in TLR4 deficient mice, and well as
limited gap formation evoked by hypoxia-reoxygenation in human microvascular
endothelial monolayers treated with TLR4 blockers (1,2). TLR4 may mediate inflammation
of lung endothelial cells in hemorrhagic shock (3). Sustained IR injury results in loss of
viability in tissue associated with increased caspase-3 expression (marker of apoptosis). Our
previous studies have shown pro-survival effects of the cytochrome P450 metabolite of
arachidonic acid 20-HETE, with decreased apoptosis in pulmonary arteries treated with 20-
HETE then exposed to hypoxia reoxygenation (4). The present investigations were
undertaken to determine whether an analog of 20-HETE, N-[20-hydroxyeicosa-5(Z),14(Z)-
dienoyl]glycine (20-5,14-HEDGE) would also impart protection to rat lung tissue exposed
in vivo to warm ischemia by reducing caspase 3 activation, or modify innate immune system
mediators HMGB1 and TLR4. Because 20-HETE has been reported to be pro-apoptotic to
brain (5), kidneys (6) and heart (7) in some injury models, we examined the effects of
treatment by 20-5,14-HEDGE on apoptosis on these vital organs.
Material and Methods
Materials
Caspase 3 Fluorimetric Assay Kit (Sigma-Aldrich, St. Louis, MO, cat# CASP3F), Vybrant
MTT Cell Proliferation Assay Kit (Invitrogen Corporation, Carlsbad, CA, cat# v13154),
Protein determination kit (BioRad, Hercules, CA, cat# 500-0006). 20-5,14-HEDGE (N-[20-
hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine) was synthesized in the laboratories of Dr. John
Falck. The structures of 20-HETE and 20-5,14-HEDGE appears in figure 1. The 20-HETE
analog 20-5,14-HEDGE behaves as 20-HETE (8). 20-HETE is metabolized rapidly in vivo,
is a substrate for lipoxygenases and cyclooxygenases, and also autooxidizes. 20-5,14-
HEDGE is more stable in vivo, and unlike 20-HETE is not a substrate for lipoxygenases or
cyclooxygenases.
The IR model—All studies were performed under approval of the Medical College of
Wisconsin Institutional Animal Care and Use Committee and in compliance with the
National Research Council’s Guide for the Care and Use of Laboratory Animals. Male
Sprague Dawley rats (200-400 gm) were used for these experiments. Sixty minutes before
surgery, vehicle (100 mM NaPO4 buffer, pH 9.0 + 0.1% ethanol) or 20-5,14 HEDGE (30
mg/kg in NaPO4 buffer) was injected intraperitoneally. Anesthesia was achieved with
isoflurane throughout the experiment. Body temperature was maintained with a warming
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table. A femoral arterial line was placed for blood collection as well as blood pressure and
heart rate measurements. A tracheotomy was performed and the rat ventilated with a FiO2 of
0.6 with tidal volumes of 7 ml/kg at a rate of ~85 breaths per minute adjusted to maintain
eucapnea. Rats were given atropine sulfate (0.4 mg/kg, intraperitoneal (IP)), heparin (500
units, IP; APP Pharmaceuticals, # 504011), and 0.9% sodium chloride (1.5 mL, IP every
hour).
A midline incision was made and the chest opened to access the left hilum. The left
pulmonary artery, vein and bronchus were stripped of connective tissue, then occluded with
a microvascular clamp to induce ischemia. After 60 minutes the clamp was removed to
permit reperfusion and ventilation. Arterial blood gases were obtained pre-clamp and 120
minutes after reperfusion. Rats were exsanguinated and the heart and lungs were removed en
bloc as well as brain, kidneys and heart for studies detailed below. Sham operated animals
underwent the same procedures except the clamp was not applied to the hilum.
Caspase 3 activity and MTT—Caspase 3 activity is an indicator of apoptosis via the
intrinsic or extrinsic pathways. Caspase-3 activity was determined using Ac-DEVD-AMC as
a substrate as previously reported by us (9). The MTT assay was applied as an index of cell
survival (4). The results are expressed as OD/g wet weight lung tissue (mean ± SEM).
Western blots of TLR4 and HMGB1—Whole lung homogenates in a buffer
supplemented with protease inhibitor cocktail were centrifuged for 10 min at 20,000 g.
Western blot analysis was performed as described previously (9). Blots were developed with
a primary antibody to TLR4 (R&D Systems, # AF1478) β-actin (Sigma #A2228) or
HMGB1 (R&D Systems, # MAB1690), matched secondary antibodies conjugated to
horseradish peroxidase, then visualized using ECL detection reagent (Pierce # 32106). The
relative densities of protein bands were compared in scanned images with β-actin used to
correct for protein loading.
Histology—Sections of paraffin-embedded lungs were stained for hematoxylin and eosin,
or myeloperoxidase by immunohistochemistry. Primary antibodies for myeloperoxidase
(Abcam, # ab45977) with matched isotype HRP-conjugated secondary antibodies were used
in IHC studies. Hemorrhage and myeloperoxidase were quantified using MetaMorph to
threshold based on hue, saturation and intensity in images by an individual blinded to the
treatment groups. Threshold settings were kept constant for all images in all groups and the
total thresholded area was recorded.
Statistical analysis—For all endpoints, three groups of animals were studied: sham,
vehicle or 20-5,14-HEDGE pretreatment groups. All analyses were not performed on all
rats, as some (e.g. histological analysis and caspase 3 activity) were mutually exclusive. For
each assay, typically 5-8 separate rats “n”s were studied. The number of rats “n”s for each
group appear in the figure legends, figures or tables. Comparisons between groups for all
experiments were performed using one-way analysis of variance. When between-group
differences were found, a Holm-Sidak post hoc test was employed for pairwise multiple
comparisons. Unadjusted p values are provided, with asterisks to indicate those which are
less than critical levels, and thus significant. All grouped data are presented as mean ±
standard error of the mean (SEM).
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Results
Hemodynamic and arterial blood gas variables in IR model
Table 1 shows values for blood pressure, heart rate, hemoglobin, and arterial blood gases for
sham operated animals, vehicle treated, and 20-5,14-HEDGE treated rats. All animals
maintained good oxygenation, blood pressures and acid base balance throughout the
experiments. Mean arterial pressures were not increased in rats treated with 20-5,14-
HEDGE, important observations because increased synthesis of this lipid is associated with
systemic hypertension (10). Rats treated with 20-5,14-HEDGE exhibited higher pO2s at the
end of the experiment than those treated with vehicle.
Morphology
The gross appearance of sham lungs and most of the right lung of IR animals was light pink
at harvesting. Small areas of hemorrhage were observed in the right lung of some of the
vehicle IR animals. The entire ischemic left lung looked hemorrhagic in vehicle treated IR
animals (figure 1b). In rats preconditioned with 20-5,14-HEDGE, less gross hemorrhage
was visible (figure 1c).
Microscopic studies of lungs
Left lungs from vehicle-treated rats exhibited areas of atelectasis and microscopic
hemorrhage (figure 1d). To quantify the hemorrhage, the hue and intensity of red color in
H&E slides was determined. Red color was increased in left IR lungs of vehicle treated rats
(Table 2) over that of contralateral right lungs lending support and quantification to
observations of gross hemorrhage. Treatment with 20-5,14-HEDGE prevented hemorrhage.
Vehicle IR lungs also exhibited infiltrating cells in H&E sections. Immunohistochemical
analysis with myeloperoxidase antibodies confirmed the presence of neutrophils (figure 2a-
d). Quantification of the brown signal for MPO showed that the degree of PMN infiltration
was attenuated in the rats preconditioned with 20-5,14-HEDGE (Table 3).
Effect 20-5,14-HEDGE on caspase 3 activity
IR resulted in an increase in caspase 3 activity in the left lung compared to the right lung in
rats preconditioned by vehicle (p<0.05; Table 4). Preconditioning with 20-5,14-HEDGE
decreased caspase 3 activity in the ischemic lung to levels which were not different from
those of the non-ischemic right lung. Caspase 3 activity in the lungs of the sham operated
animals was lower than that observed in the ischemic left lungs, but not different from that
of either lung in rats treated with 20-5,14-HEDGE. Caspase 3 activity was also measured in
kidney, brain and heart tissue (data not shown). Caspase 3 activation in these organs was not
different in any of the three groups (ANOVA p>0.2).
Cell viability determined by MTT reduction
As a second marker of cell injury, we examined MTT incorporation into lung tissue. MTT
reduction (OD normalized to wet weight lung tissue) was reduced in ischemic relative to
non-ischemic lungs only in the vehicle preconditioned animals (97 ± 3 to 88 ± 2; p=0.04).
Ratios of left to right MTT values for sham or 20-5,14-HEDGE groups or comparisons of
left or right MTT values between groups were not different.
Effect of 20-5,14-HEDGE on IR-stimulated HMGB1 and TLR4 expression
TLR4 protein was increased in homogenates of ischemic left lungs compared to that of right
lungs in vehicle controls (figure 3a and 3b). Preconditioning with 20-5,14-HEDGE
attenuated the IR-stimulated expression of TLR4 in the ischemic left lung such that it was
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not different from the right lungs, and lower than that of left lungs from vehicle-treated
animals.
Like TLR4, HMGB1 expression was increased in left IR lungs over that in right lungs from
IR rats (figure 4a and 4b). Pretreatment with 20-5,14-HEDGE blunted IR-induced increases
in HMGB1 expression such that it was not different from the right lungs as well as the levels
determined in the sham operated animal’s left and right lungs.
Comment
Our work describes several novel findings. HMGB1 and TLR4 expression are increased
within 2 hours following ischemic injury to the lung. IR injury is associated with gross and
microscopic evidence of hemorrhage and atelectasis, as well as an influx of PMNs. 20-5,14-
HEDGE protects against (i) IR-associated hemorrhage (ii) decreases in oxygenation and (iii)
increases in HMGB1, TLR4 and caspase 3 in this model. These data suggest that 20-5,14-
HEDGE decreases the inflammatory response and protects against apoptosis through
pathways including diminished activation of the innate immune system. Finally, a single
dose of 20-5,14-HEDGE does not increase apoptosis in vital organs other than the lung
including brain, heart and kidneys.
Apoptosis is a well recognized feature of transplanted lungs subjected to IR (11,12), with up
to 35% of the cells in human transplanted lung exhibiting TUNEL positivity 120 minutes
after reperfusion. Feng et al (13) identified an increase in caspase 3 mRNA which peaks 4
hours after reperfusion in a rat model of warm lung IR. Within 24 hours of reperfusion,
caspase 3 mRNA had returned to baseline. Zhang et al (14) described decreased injury in rat
lung IR after silencing caspase 3 activity with siRNA delivered via inhalation 48 hours prior
to injury. We now report elevated caspase 3 activity and decreased MTT incorporation in
this rodent model of warm ischemia of the lung within 2 hours of reperfusion.
Both gross examination and H&E studies confirm hemorrhage as a consistent feature of left
IR lungs in our studies, as well as atelectasis. Better maintenance of pO2s in 20-HETE
treated animals supports less atelectasis or hemorrhage, and/or decreased microvascular
permeability injury. Our data also identify an influx of inflammatory cells in IR lungs two
hours after reperfusion in the ischemic lung.
Myeloperoxidase IHCs confirm neutrophil influx. Feng and colleagues (13) also observed a
recruitment of PMNs accompanied by an increase in myeloperoxidase activity in their
studies of rat lung IR. These values peaked 4 hours after injury, then fell to baseline values
after 3 days.
Lung reperfusion following ischemia invokes an inflammatory response which has been
reported to activate components of the innate immune system including complement and
Toll like receptors, particularly TLR4 (1). Engagement of TLR4 receptors activates NF-κB,
phosphorylation of p38, ERK and JNK, and signaling pathways that result in non-
cardiogenic pulmonary edema and inflammation in part due to cytokine release (1,2,15).
TLR4-deficient mice enjoy protection from lung IR based upon decreased vascular
permeability, diminished BAL accumulation of neutrophils and decreased activation of NF-
κB and JNK (2). Using chimeric mice, Zanotti et al (1) reported that TLR4 on lung
parenchymal cells, as opposed to myeloid cells, is critical for increased vascular
permeability in lung IR. IR remote from the lung also appears to increase lung TLR4
expression; intestinal ischemia in mice results in enhanced lung TLR4 expression and
inflammatory cell influx, and pulmonary neutrophil recruitment is substantially reduced in
TLR4 deficient hosts (16). Our studies demonstrate an increase in TLR4 protein in ischemic
left lungs over that of matched non-ischemic right lungs within 2 hours of reperfusion
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(figure 3). Because (i) TLR4 expression is increased coincident with neutrophil recruitment
in our model (ii) neutrophils are known to express TLR4 which contributes to lung injury
after donor brain death (17) and (iii) IR lungs from hosts treated with 20-5,14-HEDGE
exhibit decreased TLR4 expression as well as decreased MPO by IHC, we postulate that
neutrophils contribute substantially to and are essential for the full increase in TLR4
expression characteristic of this model. The beneficial effect of 20-5,14-HEDGE on both
TLR4 and MPO in IR lungs could be attributable to effects on either neutrophils (figure 2)
or lung parenchymal cells (1).
A key endogenous ligand for TLR4 is HMGB1. HMGB1 is a non-histone DNA binding
protein normally present in the nucleus of cells. With injury this protein can be released
from damaged cells, where it amplifies inflammation through binding to receptors including
TLR2, TLR4 and receptors for advanced glycation products (18). Binding of HMGB1 to
TLR4 activates NFκB and MAP kinase, and increases expression of intercellular adhesion
molecule-1 (ICAM-1) and E-selectin in rat aortic endothelial cells (18). This pathway is
thought to be key to recruitment of leukocytes to injured tissues (19). To our knowledge,
increases in HMGB1 have not been previously reported in lung IR, but these data are
consistent with lung tissue injury.
Cytochrome P450 is the primary isoform which catalyzes the conversion of arachidonic acid
into 20-HETE, and is expressed in several cell types in the lung including epithelium,
alveolar macrophages, vascular smooth muscle cells, and uniquely pulmonary artery
endothelial cells (BPAECs) from small arteries (20). We have previously reported that 20-
HETE has pro-survival effects in (i) BPAECs injured by starvation or lipopolysaccharide
(LPS) and (ii) ex vivo pulmonary arteries stressed by HR (4). This lipid enhances nitric
oxide release from pulmonary artery endothelial cells (21) which contributes to the
vasorelaxant and prosurvival effects in the lung (22,23). 20-HETE-induced nitric oxide
production in pulmonary artery endothelial cells is mediated by NADPH oxidase, H2O2, and
PI3-kinase/Akt (9). For these reasons, we tested the effect of 20-HETE analog 20-5,14-
HEDGE in a rat lung IR model where we note impressive protection against elevations in
caspase 3 activity, TLR4 and HMGB1 expression. One attractive hypothesis is that 20-5,14-
HEDGE protects against apoptosis and cell injury by decreasing release of HMGB1, with
less binding to TLR4 and ultimately less inflammatory response in hosts treated with this
lipid.
MTT reduction is an index of cell viability; less MTT incorporation indicates decreased cell
viability. In our IR model caspase 3 activity was roughly doubled in the left lung of vehicle-
treated rats relative to the right lung while the MTT incorporation was decreased by less
than 10%. In the short time frame after reperfusion when lungs were harvested, the extent of
apoptosis would be expected to be greater than overt cell death. Protection by 20-5,14-
HEDGE based upon both MTT incorporation and caspase-3 activation was significant.
Despite protection by 20-5,14-HEDGE in this model, several issues need additional
attention. Details of signaling mechanisms underlying 20-5,14-HEDGE protection remain to
be established. For example, 20-5,14-HEDGE increases nitric oxide production in
pulmonary artery endothelial cells (21), but the role of an increase in nitric oxide production
to the prosurvival effects in this model is unknown. Based upon elevations in HMGB-1 and
TLR4 one may speculate that treatments which interfere with this signaling pathway could
afford protection, but such interventions have not been tested in this model. Finally, the
potential of post treatment (after reperfusion) with 20-5,14-HEDGE to protect lungs is not
tested. Regardless, our data suggest the potential to salvage pulmonary tissue from ischemic
injury in peri-operative periods associated with transplant, cardiopulmonary bypass, crush
injury or others by a single administration of a naturally occurring lipid without apparent
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injury to other vital organs. Therefore additional studies to explore the mechanisms
underlying and requirements to enjoy this protection are warranted.
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Figure 1.
Chemical structure of 20-HETE and 20-5,14-HEDGE. (b and c) IR lungs from vehicle-and
20-5,14-HEDGE-treated rats. IR resulted in gross hemorrhage in the left, and to a lesser
extent, right lungs. Treatment with 20-5,14-HEDGE decreased visible hemorrhage. (d,e)
H&E sections revealed hemorrhage (arrows point to RBCs in intra-alveolar spaces) in
ischemic left lungs which exceeded that in right lungs.
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Figure 2.
(a,b,c,d) Representative IHCs demonstrate the presence of myeloperoxidase positive cells
(see arrow in figure a) in both left and right lungs of vehicle and 20-5,14-HEDGE treated
animals. MPO expression was quantitated as brown color in photomicrographic images
analyzed by an investigator blind to treatment groups. (a) Vehicle IR left lung; (b) Vehicle
IR Right lung; (c) 20-5, 14 HEDGE IR Left lung; (d) 20-5, 14 HEDGE IR Right lung.
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Figure 3.
Western blots for TLR4. (a) Representative images of western blots probed with a primary
antibody to TLR4 show increased band density in samples from vehicle treated left lung
compared to right lungs. Treatment with 20-5,14-HEDGE partially blunted IR induced
increases in TLR4 protein. (b) Average densities and standard error bars of TLR4
normalized for β -actin. “*” indicates p< critical level relative to right lung vehicle.
“#”indicates p< critical level relative to left vehicle. “n”s for paired studies appear in the bar
for right lung values.
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Figure 4.
Western blots for HMGB1. (a) Representative images of western blots probed for HMGB1.
Immunospecific band density was increased in samples from IR lungs of vehicle treated
hosts. Treatment with 20-5,14-HEDGE blunted the increase in HMGB1. Lungs from sham
operated animals showed no difference in HMGB1 levels. (b) Graph depicts average
densities and SEM of HMGB1 normalized for β-actin. “*” indicates p< critical level relative
to right lung vehicle. “n”s for paired studies appear in the bar for right lung values.
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Table 2
Percent area of the slide positive for hemorrhage in lung sections
ANOVA p<0.02 Left Lung Right Lung Holm-Sidak (unadjusted p values)
Vehicle (n=10) 5.99 ± 1.32 2.96 ± 0.34 p= .01 left vehicle vs. right vehicle*
p= .007 left vehicle vs. left HEDGE*
20-5,14-HEDGE (n=10) 2.97 ± 0.75 2.73 ± 0.46 p= 0.84 left HEDGE vs. right HEDGE
p= 0.82 right vehicle vs. right HEDGE
*
p≤ critical level
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Table 3
Percent area of the slide MPO positive in lung sections
ANOVA p<0.001 Left Lung Right Lung Holm-Sidak (unadjusted p values)
Sham (n=8) 1.14 ± 0.34 2.14 ± 0.48 p= 0.22 L sham vs R sham
p= <0.001 L sham vs L vehicle*
p= 0.8 R sham vs R vehicle
Vehicle (n=12) 4.51 ± 0.56 1.97 ± 0.14 p= 0.004 L vehicle vs R vehicle*
p= 0.006 L vehicle vs L HEDGE
20-5,14-HEDGE (n=12) 2.69 ± 0.49 2.56 ± 0.54 p= 0.82 L HEDGE vs R HEDGE
p= 0.55 R HEDGE vs R vehicle
p= 0.43 L HEDGE vs L sham
*
p≤ critical level
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Table 4
Caspase 3 activity
ANOVA p < 0.001 Left Lung Right Lung Holm-Sidak (unadjusted p values)
Sham (n=4) 108.4 ± 22.8 100 ± 11.9 p= 0.9 L sham vs R sham
p<0.0001 L sham vs L vehicle*
p=0.34 R sham vs R vehicle
Vehicle (n=12) *335.9 ± 51.0 177.8 ± 25.9 p<.004 L vehicle vs R vehicle*
p<.001 L vehicle vs L HEDGE*
20-5,14 HEDGE (n=8) 180.5 ± 28.7 136.8 ± 25.1 p=0.37 L HEDGE vs R HEDGE
p=0.91 R HEDGE vs R sham
p= 0.48 L HEDGE vs L sham
*
p≤ critical level
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